Exendin-4 for Parkinson's disease

Exendin-4 for Parkinson's disease

This review article discusses the preclinical evidence and clinical trials testing the use of a peptide agonist of the glucagon-like peptide (GLP) receptor that promotes insulin secretion in the animal models of and patient with Parkinson's disease (PD). In particular, we focus on the therapeut...

Full description

Bibliographic Details
Main Authors: Felipe de Jesús Esparza-Salazar, Alma Rosa Lezama-Toledo, Germán Rivera-Monroy, Cesario V Borlongan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Brain Circulation
Subjects:
exenatide
exendin-4
glucagon-like peptide-1
parkinson's disease
Online Access:http://www.braincirculation.org/article.asp?issn=2394-8108;year=2021;volume=7;issue=1;spage=41;epage=43;aulast=Esparza-Salazar

Internet

http://www.braincirculation.org/article.asp?issn=2394-8108;year=2021;volume=7;issue=1;spage=41;epage=43;aulast=Esparza-Salazar

Similar Items